Treace Medical Concepts (TMCI) officer uses 16,253 shares for tax or exercise costs

Rhea-AI Filing Summary

TREACE MEDICAL CONCEPTS, INC. reported that officer Scot Michael Elder, Chief Legal & Compliance Officer and Corporate Secretary, had 16,253 shares of common stock disposed of in a code F transaction, representing shares delivered or withheld for payment of an exercise price or tax liability. Following this transaction, Elder directly held 778,683 common shares, which the company notes include 590,697 restricted stock units.

Insider Trade Summary

Net Seller: 16,253 shares

Net Sell 1 txn

Insider Elder Scot Michael

Role Chief Legl & Comp Off, CorpSec

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock F1	16,253	$0.00	$0.00

Holdings After Transaction: Common Stock — 778,683 shares (Direct)

Footnotes (1)

1. F1. Includes 590,697 restricted stock units.

Key Figures

Code F shares delivered/withheld: 16,253 shares Shares held after transaction: 778,683 shares Restricted stock units included: 590,697 units

3 metrics

Code F shares delivered/withheld 16,253 shares Shares used for payment of exercise price or tax liability in common stock transaction

Shares held after transaction 778,683 shares Direct common stock holdings of Scot Michael Elder following the code F transaction

Restricted stock units included 590,697 units Restricted stock units included within Elder’s post-transaction total holdings

Key Terms

restricted stock units, code F transaction, exercise price or tax liability

3 terms

restricted stock units financial

"Includes 590,697 restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

code F transaction financial

"The filing classifies the transaction under code F"

exercise price or tax liability financial

"payment of an exercise price or tax liability"

FAQ

What insider transaction did TMCI executive Scot Michael Elder report?

Scot Michael Elder reported a code F transaction involving 16,253 shares of Treace Medical Concepts common stock, delivered or withheld to cover an exercise price or tax liability, rather than an open-market sale or purchase.

How many TMCI shares does Scot Michael Elder hold after this Form 4?

After the reported transaction, Scot Michael Elder directly holds 778,683 shares of Treace Medical Concepts common stock, which the company states includes 590,697 restricted stock units as part of that total position.

Was the TMCI Form 4 transaction by Scot Michael Elder a market sale?

The filing classifies the transaction under code F, meaning 16,253 shares were delivered or withheld to pay an exercise price or tax liability, rather than being sold in a standard open-market transaction.

What does the footnote on Scot Michael Elder’s TMCI holdings explain?

The footnote explains that Elder’s post-transaction holdings of 778,683 shares include 590,697 restricted stock units, clarifying that a substantial portion of his reported position consists of unvested or contingent equity awards.

Does the TMCI Form 4 indicate any derivative option exercises by Scot Michael Elder?

The Form 4 reports only a non-derivative code F transaction in common stock for 16,253 shares, with no separate derivative transactions or option exercises listed in the derivative transaction section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/12/2026 - 05:30 PM Accepted by SEC EDGAR 08/12/2026 - 05:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Elder Scot Michael

(Last) (First) (Middle)

C/O TREACE MEDICAL CONCEPTS, INC.

100 PALMETTO PARK PLACE

(Street)

PONTE VEDRA FLORIDA 32081

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TREACE MEDICAL CONCEPTS, INC. [ TMCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legl & Comp Off, CorpSec

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/09/2026		F		16,253	D	$0	778,683(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 590,697 restricted stock units.

	/s/ Lisa Taylor as Attorney-in-fact for Scot Elder	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)